About this trial
This clinical study aims to evaluate the periapical and clinical healing outcomes of full pulpotomy using MTA in mandibular permanent molars diagnosed with symptomatic irreversible pulpitis. Patients will be stratified based on the presence or absence of apical periodontitis. Clinical and radiographic assessments will be conducted at baseline, 6 months, and 12 months to compare healing outcomes between groups. The study seeks to determine the effectiveness of full pulpotomy as a less invasive alternative to root canal treatment, even in teeth with apical pathosis.
Eligibility criteria
Qualifiers
The patient should be ≥18 years of age.
Restorable mature permanent 1st and 2nd Mandibular molars with extremely deep caries (≥2/3 dentine involvement)
Tooth should give positive response to pulp sensibility testing.
Radiographic finding of periapical index (PAI) score >/=3 (for test group) , score </= 2 (for control group)
Disqualifiers
Teeth with immature roots.
No pulp exposure after caries excavation.
Bleeding could not be controlled in 10 minutes.
Signs of pulpal necrosis, sinus tract, swelling, insufficient bleeding after pulp exposure.
Trial design
Treatments tested in this trial
- Full pulpotomy in adults ≥18 years with restorable mandibular first or second molars diagnosed with irreversible pulpitis, with or without apical periodontitis.